Mer receptor tyrosine kinase is a therapeutic target in pre–B-cell acute lymphoblastic leukemia

av Linger, Rachel M. A., Lee-Sherick, Alisa B., DeRyckere, Deborah, Cohen, Rebecca A., Jacobsen, Kristen M., McGranahan, Amy, Brandão, Luis N., Winges, Amanda, Sawczyn, Kelly K., Liang, Xiayuan, Keating, Amy K., Tan, Aik Choon, Earp, H. Shelton, Graham, Douglas K.
Publicerad 2013

MERTK receptor tyrosine kinase is a therapeutic target in melanoma

av Schlegel, Jennifer, Sambade, Maria J., Sather, Susan, Moschos, Stergios J., Tan, Aik-Choon, Winges, Amanda, DeRyckere, Deborah, Carson, Craig C., Trembath, Dimitri G., Tentler, John J., Eckhardt, S. Gail, Kuan, Pei-Fen, Hamilton, Ronald L., Duncan, Lyn M., Miller, C. Ryan, Nikolaishvili-Feinberg, Nana, Midkiff, Bentley R., Liu, Jing, Zhang, Weihe, Yang, Chao, Wang, Xiaodong, Frye, Stephen V., Earp, H. Shelton, Shields, Janiel M., Graham, Douglas K.
Publicerad 2013